Breast Cancer 360
The NanoString Breast Cancer 360 panel provides a unique 360-degree view of gene expression for the breast tumor microenvironment and immune response to help assess immunotherapy efficacy. With the NanoString Breast Cancer 360 panel, researchers can now more quickly decode the complexities of breast cancer biology, develop novel breast cancer gene signatures, and categorize disease heterogeneity.
Expertly curated, comprehensive content includes 770 genes across 23 key breast cancer pathways and processes
Conduct immune cell population abundance of: Cytotoxic Cells, CD8+ T Cells, Macrophages, Mast Cells, Tregs
Details & data
The NanoString Breast Cancer 360 panel includes expertly curated 770 genes across 23 categories of breast cancer tumor biology to support the evaluation of pathways and process, as well as novel signature development.
|Cell Cycle||ER Signaling||Chromatin Modification||Hedgehog||MAPK||Wnt|
|Triple Negative Tumor Biology||Cancer Progression EMT||Immune Cell Marker|
|Tumor Metabolism||Microenvironment Tissue Marker||Immune Infiltration|
|Tumor Proliferation||Cancer Progression||Immune Response|
Genes in panel
Need CLIA Certified NanoString Services?
Fill out this form and one of our scientists will contact you.
Published use of this panel
Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747-52.2.